Trials / Completed
CompletedNCT04703881
Tolerance and Acceptability Evaluation AYMES ActaGain
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 17 (actual)
- Sponsor
- Aymes International Limited · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate tolerance and acceptability of 'AYMES ActaGain' in patients requiring supplementary oral nutritional support compared with currently available alternatives.
Detailed description
To evaluate tolerance and acceptability of 'AYMES ActaGain' in patients requiring supplementary oral nutritional support compared with currently available alternatives, measuring outcomes of GI effects, Compliance, product preference, convenience etc. To obtain data to support an ACBS submissions for 'AYMES ActaGain' (to allow for prescription in the community at NHS expense).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | AYMES ActaGain | AYMES ActaGain is a Food for Special Medical Purposes (FSMP) and must, therefore, be used under medical supervision. It is designed as a supplement to the diet but can also be used as a sole source of nutrition. |
Timeline
- Start date
- 2020-07-01
- Primary completion
- 2020-10-01
- Completion
- 2020-10-01
- First posted
- 2021-01-11
- Last updated
- 2021-01-11
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT04703881. Inclusion in this directory is not an endorsement.